P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS

ABSTRACT:

SUBMITTER: Kulasekararaj A 

PROVIDER: S-EPMC9429440 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature